Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 78201-78250 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05982301
Sintilimab Combined With Modified FLOT Regimen in the Treatment of Metastatic Gastric Cancer
PHASE2Recruiting
87 participants
Started: Feb 9, 2023 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT04959929
Wearable Focal Vibration for Chemotherapy-Induced Peripheral Neuropathy
NAActive, not recruiting
15 participants
Started: Feb 9, 2023 · Completed: Jul 1, 2025
1 condition1 sponsor1 location
NCT05519475
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
PHASE2Recruiting
90 participants
Started: Feb 9, 2023 · Completed: Sep 8, 2027
1 condition1 sponsor71 locations
NCT05653310
Tradipitant for Functional Dyspepsia
PHASE2Enrolling by invitation
60 participants
Started: Feb 9, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05599256
Prevention of Severe Acute Graft-versus-host Disease in Pediatric Patients Using a daGOAT Model
PHASE2Recruiting
40 participants
Started: Feb 9, 2023 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT05854017
Effects of a Theanine for Stress Relief Formulation in Individuals Who Report Occasional Moderate High Levels of Stress.
NAActive, not recruiting
104 participants
Started: Feb 9, 2023 · Completed: Aug 20, 2025
1 condition1 sponsor1 location
NCT05702658
The Effectiveness of an Autistic-delivered Peer-support Intervention for Autistic Adults: Community Autism Peer Specialist (CAPS) Program
NAActive, not recruiting
40 participants
Started: Feb 9, 2023 · Completed: Aug 31, 2025
1 condition3 sponsors1 location
NCT06778174
Prospective Analysis of the Treatment of Progressive Familial Intrahepatic Cholestasis (TreatFIC)
N/ARecruiting
200 participants
Started: Feb 9, 2023 · Completed: Dec 31, 2033
1 condition1 sponsor1 location
NCT05621317
A Safety and Efficacy Study of PVX108 in Children and Adolescents With Peanut Allergy
PHASE2Active, not recruiting
90 participants
Started: Feb 9, 2023 · Completed: Jun 30, 2027
4 conditions1 sponsor14 locations
NCT05766059
Novel Non-invasive Brain Stimulation Techniques in Neurological Rehabilitation
NARecruiting
36 participants
Started: Feb 8, 2023 · Completed: Sep 30, 2026
3 conditions1 sponsor1 location
NCT06463899
Evaluation of the Effectiveness of the Administration of Local Anesthetics Via Two Catheters Placed During Surgery, and Study of the Benefits on Respiratory Function and Therefore on Recovery Time
NARecruiting
114 participants
Started: Feb 8, 2023 · Completed: Feb 8, 2026
1 condition1 sponsor1 location
NCT06172530
Observational Study on the Improvement of Dry Eye Syndrome, Treatment Satisfaction, and Intraocular Tolerance With Diquasol Eye Drops
N/ARecruiting
2,000 participants
Started: Feb 8, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05714748
Application of mRNA Immunotherapy Technology in Epstein-Barr Virus-related Refractory Malignant Tumors
PHASE1Active, not recruiting
19 participants
Started: Feb 8, 2023 · Completed: May 31, 2025
1 condition1 sponsor1 location
NCT05625802
Erector Spinae Plane Block for Uncomplicated Renal Colic
PHASE2Recruiting
60 participants
Started: Feb 8, 2023 · Completed: Nov 30, 2025
2 conditions1 sponsor1 location
NCT05731245
Ropeginterferon Alfa 2b for Early MyelofibrosisDIPSS Low/Intermediate-1 Risk Myelofibrosis
PHASE2Recruiting
50 participants
Started: Feb 8, 2023 · Completed: Oct 12, 2026
1 condition1 sponsor1 location
NCT05731271
A First-in-Human, Phase 1 Study of TST003 in Subjects With Solid Tumors
PHASE1/PHASE2Active, not recruiting
111 participants
Started: Feb 8, 2023 · Completed: Aug 31, 2025
3 conditions1 sponsor3 locations
NCT05501483
Adipose Tissue Heterogeneity and Its Link to Type 2 Diabetes
NARecruiting
60 participants
Started: Feb 8, 2023 · Completed: Dec 31, 2032
1 condition2 sponsors1 location
NCT03820687
Improving Informed Decision Making for Cancer Clinical Trial Participation
NAActive, not recruiting
581 participants
Started: Feb 8, 2023 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT04882475
Biological Insights of First Relapsed-refractory Patients With Mantle Cell Lymphoma: the MANTLE-FIRST BIO Study.
N/AActive, not recruiting
160 participants
Started: Feb 8, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor16 locations
NCT05707910
Clinical Study of Therapeutic Immunological Agent for EBV-positive Advanced Malignant Tumors
PHASE1Recruiting
19 participants
Started: Feb 8, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05500443
The DANish COronary DEcalcification (DANCODE) Trial
NAActive, not recruiting
400 participants
Started: Feb 8, 2023 · Completed: Nov 30, 2029
1 condition1 sponsor3 locations
NCT05912348
The Effects of an Obesogenic Lifestyle in Recreationally Active, Young Adults
NARecruiting
45 participants
Started: Feb 8, 2023 · Completed: Sep 30, 2026
4 conditions1 sponsor1 location
NCT05706909
The Use of Genex in the Management of Early-Stage Osteonecrosis of the Femoral Head
N/AActive, not recruiting
22 participants
Started: Feb 8, 2023 · Completed: Jul 31, 2027
2 conditions2 sponsors1 location
NCT06302608
Safety and Efficacy Study of NGGT001 in Bietti Crystalline Corneoretinal Dystrophy
EARLY_PHASE1Active, not recruiting
6 participants
Started: Feb 8, 2023 · Completed: May 29, 2028
1 condition1 sponsor1 location
NCT05413473
Northern Alberta Linac-MR Image-Guided Radiotherapy (Northern LIGHTs-2)
PHASE1/PHASE2Recruiting
99 participants
Started: Feb 8, 2023 · Completed: Jan 31, 2030
1 condition1 sponsor1 location
NCT03762395
Anti Inflammatory Lipid Mediators in Asthma Lipid Anti-Inflammtory Mediators in Asthma
PHASE2Recruiting
60 participants
Started: Feb 8, 2023 · Completed: Jan 30, 2030
2 conditions3 sponsors1 location
NCT05355337
Pramipexole for Anhedonic Depression
PHASE3Active, not recruiting
120 participants
Started: Feb 8, 2023 · Completed: Sep 30, 2025
3 conditions2 sponsors1 location
NCT05771844
Home Sleep Therapy for Older Adults With MCI
NARecruiting
60 participants
Started: Feb 8, 2023 · Completed: Jun 1, 2026
5 conditions3 sponsors2 locations
NCT05536804
A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
PHASE2Active, not recruiting
140 participants
Started: Feb 8, 2023 · Completed: Oct 31, 2026
5 conditions1 sponsor27 locations
NCT05578976
A Study to Evaluate Change in Disease Activity of Subcutaneous (SC) Epcoritamab Combined With Intravenous and Oral Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone (R-CHOP) or R-CHOP in Adult Participants With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)
PHASE3Active, not recruiting
900 participants
Started: Feb 8, 2023 · Completed: Dec 31, 2029
1 condition1 sponsor331 locations
NCT05098717
End-expiratory Trans-pulmonary Pressure Guided PEEP Titration in Patients With Pulmonary Fibrosis and UIP Pattern Undergoing Mechanical Ventilation
N/ARecruiting
40 participants
Started: Feb 8, 2023 · Completed: Jan 1, 2027
2 conditions1 sponsor1 location
NCT06266143
A Trial of Y101D in Combination With Gemcitabine and Albumin Paclitaxel in Patients With Advanced Pancreatic Cancer
PHASE1/PHASE2Active, not recruiting
71 participants
Started: Feb 8, 2023 · Completed: Oct 20, 2025
1 condition1 sponsor1 location
NCT06964581
Cognitive Rehabilitation of Deficits in Patients With Multiple Sclerosis
NARecruiting
60 participants
Started: Feb 8, 2023 · Completed: Sep 30, 2025
4 conditions1 sponsor1 location
NCT05707364
Feasibility and Efficacy Study for a Pre-visit Lab Protocol for Adult Medicine Physicals
N/AEnrolling by invitation
301,000 participants
Started: Feb 8, 2023 · Completed: May 1, 2025
3 conditions2 sponsors1 location
NCT05423912
Keeping on Course: A Communication-Focused Psychoeducational Program
NARecruiting
48 participants
Started: Feb 8, 2023 · Completed: Nov 30, 2025
1 condition3 sponsors1 location
NCT06017362
Clinical Trial to Determine the Efficacy and Safety of Insulin Eye Drops in Dry Eye in Patients with Topical Hypotensors
PHASE4Recruiting
100 participants
Started: Feb 8, 2023 · Completed: Feb 8, 2026
2 conditions1 sponsor1 location
NCT05576285
Retinal Imaging Study of Children That Might be at Risk of Having Retinal Hemorrhages
N/ARecruiting
1,500 participants
Started: Feb 8, 2023 · Completed: Feb 8, 2026
3 conditions1 sponsor1 location
NCT05727605
Neurocognition After Radiotherapy in CNS- and Skull-base Tumors
NARecruiting
120 participants
Started: Feb 8, 2023 · Completed: Feb 1, 2027
6 conditions3 sponsors3 locations
NCT05267340
Neural Mechanisms of Meditation Training in Healthy and Depressed Adolescents: An MRI Connectome Study PART 2
NARecruiting
120 participants
Started: Feb 8, 2023 · Completed: Aug 31, 2025
3 conditions2 sponsors1 location
NCT05873803
The Study of GR1802 in Patients with Chronic Rhinosinusitis with Nasal Polyps
PHASE2Active, not recruiting
70 participants
Started: Feb 8, 2023 · Completed: Dec 30, 2024
1 condition1 sponsor1 location
NCT05886218
Quantitative Neuromuscular Monitoring and Gastric Bypass Surgery
N/ARecruiting
215 participants
Started: Feb 8, 2023 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT06464458
Optimizing the Management of Sickle Cell Patients on Hydroxyurea: The Value of Therapeutic Pharmacological Monitoring
NARecruiting
30 participants
Started: Feb 8, 2023 · Completed: Aug 7, 2025
1 condition1 sponsor1 location
NCT05370144
A Study Involving Neoadjuvant Chemoradiotherapy with Hypofractionated Radiotherapy in Patients with Esophageal and Gastroesophageal Junction Adenocarcinoma
NARecruiting
42 participants
Started: Feb 8, 2023 · Completed: Feb 3, 2028
1 condition1 sponsor1 location
NCT05713214
Long-term Follow-up After Adoptive Transfer of Genetically Modified Cell Products
N/ARecruiting
1,000 participants
Started: Feb 8, 2023 · Completed: Dec 1, 2052
2 conditions1 sponsor1 location
NCT06127238
Study of ST-1898 in Advanced Renal Cell Carcinoma
PHASE1/PHASE2Active, not recruiting
90 participants
Started: Feb 7, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05431296
Glucose Monitoring After Acute Myocardial Infarct in People With Diabetes
NARecruiting
160 participants
Started: Feb 7, 2023 · Completed: Feb 28, 2025
4 conditions1 sponsor1 location
NCT05649904
AFFECT Study for Patients With Intraventricular Hemorrhage, Subarachnoid Hemorrhage, Subdural Hematoma, and Ventriculitis
NARecruiting
240 participants
Started: Feb 7, 2023 · Completed: Jan 31, 2026
4 conditions2 sponsors1 location
NCT05794087
The Role of Macrophage Activation in Lung Injury Following Ozone Exposure
NARecruiting
120 participants
Started: Feb 7, 2023 · Completed: Jun 1, 2027
1 condition2 sponsors1 location
NCT05633914
Tucidinostat and Nab-paclitaxel in Advanced HR+/HER2- Breast Cancer
PHASE2Recruiting
90 participants
Started: Feb 7, 2023 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT05705791
Clinical Investigation Evaluating Safety and Efficacy of Selective Intra-arterial 166Holmium Radiation Therapy in Combination With Atezolizumab and Bevacizumab for Non Resectable Hepatocellular Carcinoma
NAActive, not recruiting
33 participants
Started: Feb 7, 2023 · Completed: Aug 31, 2026
1 condition1 sponsor6 locations